Ophthalmology celebrates 50 years of groundbreaking innovations, highlighting anti-VEGF therapies, OCT imaging, and future ...

Ixo-vec reduced anti-VEGF injection frequency and was well tolerated in patients with wet AMD. A phase 3 pivotal trial ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Code Vein 2 Lets You Explore With A Badass Motorcycle You won't ...

Diaz M, et al. Analysis of retinal vascular caliber alterations with age and sex in health and disease. Presented at: Association for Research in Vision and Ophthalmology meeting; May 4-8, 2025 ...

The White House’s announcement that President Trump has a common chronic vein condition marked a rare glimpse into the health of the oldest person to be elected U.S. president, whose campaign ...

A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is associated with worse outcomes in patients who already have the condition.

"These updated Phase 2 results demonstrate MGB’s potential to address a significant unmet need in retinal vascular diseases," said Jeff Cleland, Ph.D., CEO of Ashvattha Therapeutics.

Dilated fundal examination showed right clear retina and optic disc with no macular changes (Figure 1(a)) with left widespread retinal vasculitis, severe papillitis and prominent vascular sheathing, ...

Regeneron seeks FDA approval for EYLEA HD, a novel treatment for retinal vein occlusion, offering less frequent dosing.

Researchers have successfully developed a novel drug to restore vision. The treatment method restores vision through retinal nerve regeneration.

New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients with more treatment options, optimizing timing, and introducing ...